Hirotsu Bio Science has decided to apply measures based on government policies and action plans.
We have received a request from some of the clinics which handle N-NOSE to postpone/ suspend the implementation of the test. (for the details, please directly confirm with clinics).
In our inspection center, for the safety of the employees, it is planned to decrease its activities.
Hirotsu Bio Science will continue to prioritize the prevention of the spread of the new coronavirus infection both inside and outside of the company and ensure the safety of its employees and business partners.
Thank you for your understanding.
A book "Prime Archives in Cancer Research" was published. This book includes our joint paper with Osaka University on pancreatic cancer "Applic . . .
2020.06.18N-NOSE was introduced in a web magazine "NikkeiLUXE (published by Nikkei BP)" as a new cancer test that detects cancer in early stages with high . . .
2020.06.16A review on our collaborative study between Graduate School of Medicine of Osaka University (review on biological diagnosis: joint research cour . . .
2020.06.11